Webinar

UC-II: A Game-Changing Ingredient for the Joint Health Category

Published

Format: External webinar | Document type: Webinar

Bone and Joint Health online event 2016
UC-II® is a novel patented form of undenatured type II collagen derived from chicken sternum cartilage. Since its initial discovery, InterHealth has continued to systematically build scientific support surrounding this ingredient. UC-II has undergone rigorous third-party research and testing for efficacy, safety and quality. Three randomized, double-blind, controlled trials (RCTs) show that 40 mg of UC-II once-a-day supports joint comfort, mobility and flexibility. To the best of our knowledge, UC-II is the only joint health ingredient that has been tested in healthy active exercising adults, which provides additional substantiation for its joint health benefits. UC-II is a FDA-notified and published new dietary ingredient (NDI). This presentation will discuss the results from the two recently completed RDBPC trials conducted in healthy as well as in knee OA subjects. The webinar will also highlight on how UC-II is impacting the growth of the top brands in the joint health segment.

Speakers

James Lugo PhD James Lugo PhD Chief Scientific Officer
InterHealth Nutraceuticals, Inc

Pat McCullough Pat McCullough Chief Commercial Officer
InterHealth Nutraceuticals, Inc

Latest content from InterHealth Nutraceuticals, Inc.

Related resources from InterHealth Nutraceuticals, Inc.

Show more

Supplier info centre